D
CRISPR Therapeutics AG CRSP
$54.13 -$0.19-0.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 38.05M 37.68M 37.31M 202.83M 202.23M
Total Other Revenue -- -- -- -- --
Total Revenue 38.05M 37.68M 37.31M 202.83M 202.23M
Cost of Revenue 420.51M 437.76M 430.90M 463.89M 484.70M
Gross Profit -382.46M -400.08M -393.59M -261.06M -282.47M
SG&A Expenses 73.76M 74.32M 72.98M 71.33M 72.20M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 494.26M 512.08M 503.88M 535.22M 556.90M
Operating Income -456.21M -474.40M -466.57M -332.39M -354.68M
Income Before Tax -463.82M -381.69M -362.67M -236.47M -263.15M
Income Tax Expenses 3.98M 3.97M 3.59M 3.12M 2.66M
Earnings from Continuing Operations -467.80 -385.66 -366.25 -239.59 -265.80
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -467.80M -385.66M -366.25M -239.59M -265.80M
EBIT -456.21M -474.40M -466.57M -332.39M -354.68M
EBITDA -437.25M -455.24M -447.31M -313.08M -335.17M
EPS Basic -5.42 -4.52 -4.36 -2.80 -3.20
Normalized Basic EPS -2.67 -2.79 -2.70 -1.73 -1.98
EPS Diluted -5.43 -4.52 -4.37 -2.84 -3.24
Normalized Diluted EPS -2.67 -2.79 -2.70 -1.74 -2.00
Average Basic Shares Outstanding 343.71M 341.56M 337.41M 331.64M 325.82M
Average Diluted Shares Outstanding 343.71M 341.56M 337.41M 333.28M 327.45M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --